CR

Cole, Ryan

OFFICER

US·SEC (Form 4)

Aurinia Pharmaceuticals Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the full record of transactions filed by Cole, Ryan. Insider active across 1 company, notably Aurinia Pharmaceuticals Inc.. In total, 4 filings have been recorded. Activity tracked since 18 May 2026. The latest transaction was disclosed on 18 May 2026 (50 - Grant of options). Regulator: SEC (Form 4). The full history is openly available.

Declarations4 total

●

Cole, Ryan

5 - Senior Officer of IssuerExecutives18 May 2026Aurinia Pharmaceuticals Inc.

13SEDI ↗

116,144 sharesRights Performance AwardTSXSEDI:4724313

●

Cole, Ryan

5 - Senior Officer of IssuerExecutives23 Mar 2026Aurinia Pharmaceuticals Inc.

13SEDI ↗

Rights Performance AwardTSXSEDI:4724311

◇

Cole, Ryan

5 - Senior Officer of IssuerExecutives18 May 2026Aurinia Pharmaceuticals Inc.

CA$1M27SEDI ↗

70,230 shares@ CA$15.280.081% mcap100.0% of flowOptionsTSXSEDI:4724310

●

Cole, Ryan

5 - Senior Officer of IssuerExecutives23 Mar 2026Aurinia Pharmaceuticals Inc.

13SEDI ↗

OptionsTSXSEDI:4724307

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

CR

Cole, Ryan

OFFICER

US·SEC (Form 4)

Aurinia Pharmaceuticals Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the full record of transactions filed by Cole, Ryan. Insider active across 1 company, notably Aurinia Pharmaceuticals Inc.. In total, 4 filings have been recorded. Activity tracked since 18 May 2026. The latest transaction was disclosed on 18 May 2026 (50 - Grant of options). Regulator: SEC (Form 4). The full history is openly available.

Declarations4 total

●

Cole, Ryan

5 - Senior Officer of IssuerExecutives18 May 2026Aurinia Pharmaceuticals Inc.

13SEDI ↗

116,144 sharesRights Performance AwardTSXSEDI:4724313

●

Cole, Ryan

5 - Senior Officer of IssuerExecutives23 Mar 2026Aurinia Pharmaceuticals Inc.

13SEDI ↗

Rights Performance AwardTSXSEDI:4724311

◇